| Del Vecchio L, Cavalli A, Locatelli F
Methoxypolyethylene glycol-epoetin beta for the treatment of anemia associated with chronic kidney disease. [Journal Article]
Drugs Today (Barc) 2008 Aug; 44(8):577-84.
Abstract | Full Citation | | Thompson CA
FDA approves new epoetin product: Roche unsure when it can market in United States. [News]
Am J Health Syst Pharm 2008 Jan 1; 65(1):10.
Full Citation | Publisher Full Text | Find Related Articles | | Klinger M, Arias M, Vargemezis V, et al.
Efficacy of intravenous methoxy polyethylene glycol-epoetin beta administered every 2 weeks compared with epoetin administered 3 times weekly in patients treated by hemodialysis or peritoneal dialysis: a randomized trial. [Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
Am J Kidney Dis 2007 Dec; 50(6):989-1000.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Fishbane S, Pannier A, Liogier X, et al.
Pharmacokinetic and pharmacodynamic properties of methoxy polyethylene glycol-epoetin beta are unaffected by the site of subcutaneous administration. [Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't]
J Clin Pharmacol 2007 Nov; 47(11):1390-7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |  |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
